Type 2 diabetes as a risk factor for cognitive impairment: current insights

References

• DanaeiGFinucaneMMLuYGlobal Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose)National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participantsLancet20113789785314021705069
   PubMed Web of Science ®Google Scholar
• Abi KhalilCRousselRMohammediKDanchinNMarreMCause-specific mortality in diabetes: recent changes in trend mortalityEur J Prev Cardiol201219337438122991697
   PubMed Web of Science ®Google Scholar
• McCrimmonRJRyanCMFrierBMDiabetes and cognitive dysfunctionLancet201237998332291229922683129
   PubMed Web of Science ®Google Scholar
• StewartRLiolitsaDType 2 diabetes mellitus, cognitive impairment and dementiaDiabet Med19991629311210229302
   PubMed Web of Science ®Google Scholar
• LiLHölscherCCommon pathological processes in Alzheimer disease and type 2 diabetes: a reviewBrain Res Rev200756238440217920690
   PubMedGoogle Scholar
• OttAStolkRPvan HarskampFDiabetes mellitus and the risk of dementia: The Rotterdam StudyNeurology19995391937194210599761
   PubMed Web of Science ®Google Scholar
• ArvanitakisZWilsonRSBieniasJLEvansDABennettDADiabetes mellitus and risk of Alzheimer disease and decline in cognitive functionArch Neurol200461566166615148141
   PubMed Web of Science ®Google Scholar
• PeilaRRodriguezBLLaunerLJHonolulu-Asia Aging StudyType 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging StudyDiabetes20025141256126211916953
   PubMed Web of Science ®Google Scholar
• OharaTDoiYNinomiyaTGlucose tolerance status and risk of dementia in the community: the Hisayama studyNeurology201177121126113421931106
   PubMed Web of Science ®Google Scholar
• ChengGHuangCDengHWangHDiabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studiesIntern Med J201242548449122372522
   PubMed Web of Science ®Google Scholar
• McKhannGMKnopmanDSChertkowHThe diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimers Dement20117326326921514250
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology19843479399446610841
   PubMed Web of Science ®Google Scholar
• JellingerKAPrevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseasesNeurodegener Dis201071–311211520173339
   PubMed Web of Science ®Google Scholar
• SchneiderJAArvanitakisZBangWBennettDAMixed brain pathologies account for most dementia cases in community-dwelling older personsNeurology200769242197220417568013
   PubMed Web of Science ®Google Scholar
• LeeSWClemensonGDGageFHNew neurons in an aged brainBehav Brain Res2012227249750722024433
   PubMed Web of Science ®Google Scholar
• LangBTYanYDempseyRJVemugantiRImpaired neurogenesis in adult type-2 diabetic ratsBrain Res20091258253319138677
   PubMed Web of Science ®Google Scholar
• MachidaMFujimakiSHidakaRAsashimaMKuwabaraTThe insulin regulatory network in adult hippocampus and pancreatic endocrine systemStem Cells Int2012201295973722988465
   PubMed Web of Science ®Google Scholar
• FarrallAJWardlawJMBlood–brain barrier: ageing and microvascular disease – systematic review and meta-analysisNeurobiol Aging200930333735217869382
   PubMed Web of Science ®Google Scholar
• KalariaRNCerebral vessels in ageing and Alzheimer’s diseasePharmacol Ther19967231932149364575
   PubMed Web of Science ®Google Scholar
• BellRDZlokovicBVNeurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s diseaseActa Neuropathol2009118110311319319544
   PubMed Web of Science ®Google Scholar
• IadecolaCNedergaardMGlial regulation of the cerebral microvasculatureNat Neurosci200710111369137617965657
   PubMed Web of Science ®Google Scholar
• MooradianADCentral nervous system complications of diabetes mellitus – a perspective from the blood–brain barrierBrain Res Brain Res Rev19972332102189164671
   PubMedGoogle Scholar
• KertiLWitteAVWinklerAGrittnerURujescuDFlöelAHigher glucose levels associated with lower memory and reduced hippocampal microstructureNeurology201381201746175224153444
   PubMed Web of Science ®Google Scholar
• CranePKWalkerRHubbardRAGlucose levels and risk of dementiaN Engl J Med2013369654054823924004
   PubMed Web of Science ®Google Scholar
• YamagishiSUedaSOkudaSFood-derived advanced glycation end products (AGEs): a novel therapeutic target for various disordersCurr Pharm Des200713272832283617897026
   PubMed Web of Science ®Google Scholar
• ValenteTGellaAFernàndez-BusquetsXUnzetaMDuranyNImmunohistochemical analysis of human brain suggests pathological synergism of Alzheimer’s disease and diabetes mellitusNeurobiol Dis2010371677619778613
   PubMed Web of Science ®Google Scholar
• BlockMLZeccaLHongJSMicroglia-mediated neurotoxicity: uncovering the molecular mechanismsNat Rev Neurosci200781576917180163
   PubMed Web of Science ®Google Scholar
• EvansJLGoldfineIDMadduxBAGrodskyGMOxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetesEndocr Rev200223559962212372842
   PubMed Web of Science ®Google Scholar
• MoreiraPISantosMSSeiçaROliveiraCRBrain mitochondrial dysfunction as a link between Alzheimer’s disease and diabetesJ Neurol Sci20072571–220621417316694
   PubMed Web of Science ®Google Scholar
• BadawiAKlipAHaddadPType 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional interventionDiabetes Metab Syndr Obes2010317318621437087
   PubMedGoogle Scholar
• AkiyamaHBargerSBarnumSInflammation and Alzheimer’s diseaseNeurobiol Aging200021338342110858586
   PubMed Web of Science ®Google Scholar
• ZhaoWQTownsendMInsulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s diseaseBiochim Biophys Acta20091792548249619026743
   PubMed Web of Science ®Google Scholar
• WatsonGSCraftSThe role of insulin resistance in the pathogenesis of Alzheimer’s disease: implications for treatmentCNS Drugs2003171274512467491
   PubMed Web of Science ®Google Scholar
• DavisSNGrannerDKInsulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreasHardmanJGGilmanAGLimbirdLEGoodman and Gilman’s the Pharmacological Basis of Therapeutics9th edNew YorkMcGraw-Hill199614871517
   Google Scholar
• WoodsSCSeeleyRJBaskinDGSchwartzMWInsulin and the blood–brain barrierCurr Pharm Des200391079580012678878
   PubMed Web of Science ®Google Scholar
• HavrankovaJRothJBrownsteinMInsulin receptors are widely distributed in the central nervous system of the ratNature19782725656827829205798
   PubMed Web of Science ®Google Scholar
• FreychetPInsulin receptors and insulin action in the nervous systemDiab Metab Res Rev2000166390392
   Web of Science ®Google Scholar
• RiveraEJGoldinAFulmerNTavaresRWandsJRde la MonteSMInsulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholineJ Alzheimers Dis20058324726816340083
   PubMed Web of Science ®Google Scholar
• ZhaoLTeterBMoriharaTInsulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer’s disease interventionJ Neurosci20042449111201112615590928
   PubMed Web of Science ®Google Scholar
• HoLQinWPomplPNDiet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s diseaseFASEB J200418790290415033922
   PubMed Web of Science ®Google Scholar
• UmegakiHPathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?Age Ageing201039181019917634
   PubMed Web of Science ®Google Scholar
• SchubertMBrazilDPBurksDJInsulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylationJ Neurosci200323187084709212904469
   PubMed Web of Science ®Google Scholar
• TalbotKWangHYKaziHDemonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineJ Clin Invest201212241316133822476197
   PubMed Web of Science ®Google Scholar
• BomfimTRForny-GermanoLSathlerLBAn anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomersJ Clin Invest201212241339135322476196
   PubMed Web of Science ®Google Scholar
• BenedictCHallschmidMHatkeAIntranasal insulin improves memory in humansPsychoneuroendocrinology200429101326133415288712
   PubMed Web of Science ®Google Scholar
• de ZeeuwDParvingHHHenningRHMicroalbuminuria as an early marker for cardiovascular diseaseJ Am Soc Nephrol20061782100210516825327
   PubMed Web of Science ®Google Scholar
• de BresserJReijmerYDvan den BergEUtrecht Diabetic Encephalopathy Study GroupMicrovascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetesDement Geriatr Cogn Disord201030538138620962529
   PubMed Web of Science ®Google Scholar
• KawamuraTUmemuraTUmegakiHEffect of renal impairment on cognitive function during a 3-year follow-up in elderly patients with type 2 diabetes: association with microinflammationJ Diabetes Investig Epub201424
   Web of Science ®Google Scholar
• UmegakiHIimuroSShinozakiTJapanese Elderly Diabetes Intervention Trial Study GroupRisk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention TrialGeriatr Gerontol Int201212Suppl 110310922435945
   PubMed Web of Science ®Google Scholar
• UmemuraTKawamuraTUmegakiHAssociation of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetesDement Geriatr Cogn Dis Extra20133121222223888167
   PubMedGoogle Scholar
• DalkaraTGursoy-OzdemirYYemisciMBrain microvascular pericytes in health and diseaseActa Neuropathol201112211921656168
   PubMed Web of Science ®Google Scholar
• WellerROMasseyAKuoYMRoherAECerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer’s diseaseAnn N Y Acad Sci200090311011710818495
   PubMed Web of Science ®Google Scholar
• van HartenBde LeeuwFEWeinsteinHCScheltensPBiesselsGJBrain imaging in patients with diabetes: a systematic reviewDiabetes Care200629112539254817065699
   PubMed Web of Science ®Google Scholar
• ManschotSMBrandsAMvan der GrondJUtrecht Diabetic Encephalopathy Study GroupBrain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetesDiabetes20065541106111316567535
   PubMed Web of Science ®Google Scholar
• KorfESvan StraatenECde LeeuwFELADIS Study GroupDiabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS studyDiabet Med200724216617117257279
   PubMed Web of Science ®Google Scholar
• LastDAlsopDCAbduljalilAMGlobal and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivityDiabetes Care20073051193119917290035
   PubMed Web of Science ®Google Scholar
• GoldSMDziobekISweatVHippocampal damage and memory impairments as possible early brain complications of type 2 diabetesDiabetologia200750471171917334649
   PubMed Web of Science ®Google Scholar
• BruehlHWolfOTSweatVTirsiARichardsonSConvitAModifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitusBrain Res2009128018619419463794
   PubMed Web of Science ®Google Scholar
• BurnsJMDonnellyJEAndersonHSPeripheral insulin and brain structure in early Alzheimer diseaseNeurology200769111094110417846409
   PubMed Web of Science ®Google Scholar
• BurnsJMHoneaRAVidoniEDHutflesLJBrooksWMSwerdlowRHInsulin is differentially related to cognitive decline and atrophy in Alzheimer’s disease and agingBiochim Biophys Acta20121822333333921745566
   PubMed Web of Science ®Google Scholar
• den HeijerTVermeerSEvan DijkEJType 2 diabetes and atrophy of medial temporal lobe structures on brain MRIDiabetologia200346121604161014595538
   PubMed Web of Science ®Google Scholar
• WilletteAAXuGJohnsonSCInsulin resistance, brain atrophy, and cognitive performance in late middle-aged adultsDiabetes Care201336244344923069842
   PubMed Web of Science ®Google Scholar
• MoranCPhanTGChenJBrain atrophy in type 2 diabetes: regional distribution and influence on cognitionDiabetes Care201336124036404223939539
   PubMed Web of Science ®Google Scholar
• BakerLDCrossDJMinoshimaSBelongiaDWatsonGSCraftSInsulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetesArch Neurol2011681515720837822
   PubMedGoogle Scholar
• SchrijversEMWittemanJCSijbrandsEJHofmanAKoudstaalPJBretelerMMInsulin metabolism and the risk of Alzheimer disease: the Rotterdam StudyNeurology201075221982198721115952
   PubMed Web of Science ®Google Scholar
• MatsuzakiTSasakiKTanizakiYInsulin resistance is associated with the pathology of Alzheimer disease: the Hisayama studyNeurology201075976477020739649
   PubMed Web of Science ®Google Scholar
• BeeriMSSilvermanJMDavisKLType 2 diabetes is negatively associated with Alzheimer’s disease neuropathologyJ Gerontol A Biol Sci Med Sci200560447147515933386
   PubMed Web of Science ®Google Scholar
• ArvanitakisZSchneiderJAWilsonRSDiabetes is related to cerebral infarction but not to AD pathology in older personsNeurology200667111960196517159101
   PubMed Web of Science ®Google Scholar
• ThambisettyMJeffrey MetterEYangAGlucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of AgingJAMA Neurol20137091167117223897112
   PubMed Web of Science ®Google Scholar
• TomitaNFurukawaKOkamuraNBrain accumulation of amyloid β protein visualized by positron emission tomography and BF-227 in Alzheimer’s disease patients with or without diabetes mellitusGeriatr Gerontol Int201313121522122680403
   PubMed Web of Science ®Google Scholar
• StrittmatterWJRosesADApolipoprotein E and Alzheimer diseaseProc Natl Acad Sci U S A19959211472547277761390
   PubMed Web of Science ®Google Scholar
• DoreGAEliasMFRobbinsMAEliasPKNagyZPresence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse StudyDiabetologia200952122551256019693485
   PubMed Web of Science ®Google Scholar
• IrieFFitzpatrickALLopezOLEnhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition StudyArch Neurol2008651899318195144
   PubMed Web of Science ®Google Scholar
• LuitseMJBiesselsGJRuttenGEKappelleLJDiabetes, hyperglycaemia, and acute ischaemic strokeLancet Neurol201211326127122341034
   PubMed Web of Science ®Google Scholar
• ReijmerYDLeemansABrundelMKappelleLJBiesselsGJUtrecht Vascular Cognitive Impairment Study GroupDisruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetesDiabetes20136262112211523349494
   PubMed Web of Science ®Google Scholar
• ReijmerYDBrundelMde BresserJKappelleLJLeemansABiesselsGJUtrecht Vascular Cognitive Impairment Study GroupMicrostructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging studyDiabetes Care201336113714422961577
   PubMed Web of Science ®Google Scholar
• Cukierman-YaffeTGersteinHCWilliamsonJDAction to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) InvestigatorsRelationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trialDiabetes Care200932222122619171735
   PubMed Web of Science ®Google Scholar
• MaggiSLimongiFNoaleMILSA Study GroupDiabetes as a risk factor for cognitive decline in older patientsDement Geriatr Cogn Disord2009271243319088471
   PubMed Web of Science ®Google Scholar
• PetersRBeckettNForetteFHYVET investigatorsIncident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialLancet Neurol20087868368918614402
   PubMed Web of Science ®Google Scholar
• UmegakiHKawamuraTMogiNUmemuraTKanaiASanoTGlucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderlyAge Ageing200837445846118339615
   PubMed Web of Science ®Google Scholar
• LaunerLJMillerMEWilliamsonJDACCORD MIND investigatorsEffects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudyLancet Neurol2011101196997721958949
   PubMed Web of Science ®Google Scholar
• LuchsingerJAPalmasWTeresiJAImproved diabetes control in the elderly delays global cognitive declineJ Nutr Health Aging201115644544921623465
   PubMed Web of Science ®Google Scholar
• IkonomovicMDKlunkWEAbrahamsonEEPost-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s diseaseBrain2008131Pt 61630164518339640
   PubMed Web of Science ®Google Scholar
• van den BergEReijmerYDde BresserJKesselsRPKappelleLJBiesselsGJUtrecht Diabetic Encephalopathy Study GroupA 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitusDiabetologia2010531586519882137
   PubMed Web of Science ®Google Scholar
• ShorrRIde RekeneireNResnickHEGlycemia and cognitive function in older adults using glucose-lowering drugsJ Nutr Health Aging200610429730116886100
   PubMed Web of Science ®Google Scholar
• WhitmerRAKarterAJYaffeKQuesenberryCPSelbyJVHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitusJAMA2009301151565157219366776
   PubMed Web of Science ®Google Scholar
• NovakVAbduljalilAMNovakPRobitaillePMHigh-resolution ultrahigh-field MRI of strokeMagn Reson Imaging200523453954815919599
   PubMed Web of Science ®Google Scholar
• KodlCTFrancDTRaoJPDiffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive functionDiabetes200857113083308918694971
   PubMed Web of Science ®Google Scholar
• ZetterbergLOWahlundKBlennowCerebrospinal fluid markers for prediction of Alzheimer’s diseaseNeurosci Lett20033521676914615052
   PubMed Web of Science ®Google Scholar
• HanssonHZetterbergPBuchhaveELondosEBlennowKMinthonLAssociation between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up studyLancet Neurol20065322823416488378
   PubMed Web of Science ®Google Scholar
• EwersMBuergerKTeipelSJMulticenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCINeurology200769242205221218071141
   PubMed Web of Science ®Google Scholar
• SchiöthHBCraftSBrooksSJFreyWHBenedictCBrain insulin signaling and Alzheimer’s disease: current evidence and future directionsMol Neurobiol201246141022205300
   PubMed Web of Science ®Google Scholar
• McIntyreRSPowellAMKaidanovich-BeilinOThe neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disordersBehav Brain Res201323716417123000536
   PubMed Web of Science ®Google Scholar
• GouwAAvan der FlierWMFazekasFLADIS Study GroupProgression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability studyStroke20083951414142018323505
   PubMed Web of Science ®Google Scholar
• van EerselMEJoostenHGansevoortRTDullaartRPSlaetsJPIzaksGJThe interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or olderPLoS One2013812e8299124367577
   PubMed Web of Science ®Google Scholar
• JoostenHvan EerselMEGansevoortRTBiloHJSlaetsJPIzaksGJCardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjectsStroke20134461543154923640826
   PubMed Web of Science ®Google Scholar
• TangJPeiYZhouGWhen aging-onset diabetes is coming across with Alzheimer disease: comparable pathogenesis and therapyExp Gerontol201348874475023648584
   PubMed Web of Science ®Google Scholar